California Cancer Reporting System Standards, Volume III

 

 

Eureka Edits

IF776: Primary Site, CS Extension

 

Edit Sets:

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

 

Fields:

Date of Diagnosis  [NAACCR #390]

Primary Site  [NAACCR #400]

Histologic Type ICD-O-3  [NAACCR #522]

Behavior Code ICD-O-3  [NAACCR #523]

CS Extension  [NAACCR #2810]

CS Mets at DX  [NAACCR #2850]

Over-ride Site/EOD/DX Dt  [NAACCR #2072]

 

Message:

IF 776:  Conflict between Primary Site, CS Extension and CS Mets at DX and OR Site EOD/Dx Dt; review needed.

 

Specification:

The edit is skipped if any of the following conditions are true:

  1. Over-ride Site/EOD/Dx Dt contains a '1' (review complete)

  2. Year of Date of Diagnosis is < 2004 or is blank or not valid

  3. Histologic Type ICD-0-3 = 9140 (Kaposi Sarcoma)

  4. Histologic Type ICD-0-3 > = 9590 (lymphoma, leukemia, or other lymphoreticular neoplasm)

  5. Behavior Code ICD-0-3 = 2 (in situ)

 

If CS Extension equals 100-300 (localized disease) and CS Mets at DX equals 00 or 99, the following Primary Site codes require review:

C069 Mouth, NOS

C260-C269 Other and ill-defined digestive organs

C390-C399 Other and ill-defined respiratory or intrathoracic sites

C409, C419 Bone, NOS

C579 Female genital system, NOS

C639 Male genital organs, NOS

 

If CS Extension= 100-320 (localized disease) and CS Mets at DX equals 00 or 99,

the following Primary Site codes require review:

C479 Peripheral nerves, NOS

C499 Connective tissue, NOS

 

If CS Extension= 100-400 (localized disease) and CS Mets at DX equals 00 or 99,

the following Primary Site codes require review:

C189 Colon, NOS and not histology 8210, 8220, 8261 and 8263

C559 Uterus, NOS

 

Historical Changes:

1/08/07:  Added SEER edit (SEER IF176).

2010 Data Changes:  CCR names (Site; CS Ext; CS Mets DX) changed to NAACCR names.  Per NAACCR v12.0